The trillion-dollar club has become crowded with mostly tech names riding the AI boom. Eli Lilly might soon join them for a ...
Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
Explore Zepbound's "Changing the Threads" exhibit, which is redefining the stigma of obesity through powerful stories and ...
American Express is an advertising partner of Motley Fool Money. The Motley Fool has positions in and recommends Amazon, Peloton Interactive, and Pfizer. The Motley Fool recommends Coinbase Global and ...
Researchers reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ...
Novo Nordisk announced Monday that it is significantly cutting the prices of its blockbuster GLP-1 drugs, Wegovy (for weight ...
Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...
Eli Lilly and Company (NYSE: LLY) is one of the 15 Best Aggressive Growth Stocks to Buy Right Now. On November 7, TD Cowen ...
Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results